Sales & Marketing News | pharmaphorum

News

Biogen offers to buy out wilting Sage for $442 million

Biogen has offered to buy all the shares in Sage Therapeutics that it doesn't already own, taking control of their novel antidepressant Zurzuvae.

News

HCP in lab coat holding a red stethoscope

UK 'needs more transparency on pharma-doctor payments'

The UK's system of disclosing payments from pharma to healthcare professionals has gaps that hide potential conflicts of interest, claims study.

News

Grifols files drug for rare bleeding disorder in the US

Grifols has filed for FDA approval of its new drug for bleeding disorder acquired fibrinogen deficiency (AFD), aiming for a first-in-class US launch.

News

11 blockbuster drugs to look out for in 2025

Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.

News

Scrabble letters spelling out 'Deep Breath'

Verona says COPD drug is off to a flying start

Verona Pharma's plans to transform COPD treatment with recently approved Ohtuvayre look like they are on course, given early sales figures.

News

MSD buys Irish vaccines plant from WuXi for €500m

MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk.

Biogen offers to buy out wilting Sage for $442 million

UK 'needs more transparency on pharma-doctor payments'

Grifols files drug for rare bleeding disorder in the US

11 blockbuster drugs to look out for in 2025

Verona says COPD drug is off to a flying start

MSD buys Irish vaccines plant from WuXi for €500m

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks